Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Novae® Dual Mobility System, Hype® Hip System

K-Number: K223745 · 2023-12-22

ApplicantSerf
Decision Date2023-12-22
Product CodeLZO
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

Novae® Dual Mobility System, Hype® Hip System is a medical device manufactured by Serf. It received FDA 510(k) clearance on 2023-12-22 under approval number K223745. The device is classified under product code LZO. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Novae® Dual Mobility System, Hype® Hip System?

Novae® Dual Mobility System, Hype® Hip System is a medical device that received FDA 510(k) clearance on 2023-12-22. It is manufactured by Serf. The 510(k) number is K223745.

When was Novae® Dual Mobility System, Hype® Hip System approved by the FDA?

Novae® Dual Mobility System, Hype® Hip System received FDA 510(k) clearance on 2023-12-22, under approval number K223745.

What company makes Novae® Dual Mobility System, Hype® Hip System?

Novae® Dual Mobility System, Hype® Hip System is manufactured by Serf.

What is the FDA product code for Novae® Dual Mobility System, Hype® Hip System?

The FDA product code for Novae® Dual Mobility System, Hype® Hip System is LZO.

Related Clinical Trials

Other Devices by Serf

Related Devices (Code: LZO)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.